On December 22, 2020, the U.S. Senate passed the "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act," extending Medicare coverage of immunosuppressive medications for the life of a kidney transplant, if no other coverage is available. A non-partisan Congressional Budget Office analysis estimated the legislation will save Medicare more than $400,000,000 over the course of 10 years by averting a return to hemodialysis for those who have had a kidney transplant. The legislation is expected to be signed into law, and will take effect in 2023. Previously, Medicare Part B covered immunosuppressive medications for 36 . . .
News Report |